Invention Grant
- Patent Title: Compound targeting IL-23A and TNF-alpha and uses thereof
-
Application No.: US16052133Application Date: 2018-08-01
-
Publication No.: US10793629B2Publication Date: 2020-10-06
- Inventor: Rachel Rebecca Barrett , Leslie S. Johnson , Sanjaya Singh , Kathleen Last-Barney , Daw-Tsun Shih , Patricia Giblin , Scott Brodeur , Nelamangala Nagaraja
- Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH , MACROGENICS, INC.
- Applicant Address: DE Ingelheim am Rhein US MD Rockville
- Assignee: BOEHRINGER INGELHEIM INTERNATIONAL GMBH,MACROGENICS, INC.
- Current Assignee: BOEHRINGER INGELHEIM INTERNATIONAL GMBH,MACROGENICS, INC.
- Current Assignee Address: DE Ingelheim am Rhein US MD Rockville
- Agency: Baker, Donelson, Bearman, Caldwell & Berkowitz PC
- Agent Robin L. Teskin
- Main IPC: C12N15/63
- IPC: C12N15/63 ; A61K39/395 ; C07K16/24 ; G01N33/574 ; C12P15/00 ; C12N5/0783 ; A61K39/00 ; C12N5/07
Abstract:
The disclosure relates to compounds specific for IL23A and TNF-alpha, compositions comprising the compounds, and methods of use thereof. Nucleic acids, cells, and methods of production related to the compounds and compositions are also disclosed.
Public/Granted literature
- US20190016794A1 COMPOUND TARGETING IL-23A AND TNF-ALPHA AND USES THEREOF Public/Granted day:2019-01-17
Information query
IPC分类:
